Literature DB >> 21246510

Hydrophobic salts markedly diminish viscosity of concentrated protein solutions.

Wei Du1, Alexander M Klibanov.   

Abstract

Reducing viscosities of concentrated solutions of therapeutic proteins is important for their subcutaneous and intravenous delivery. Although inorganic salts and optimizing the pH were previously reported to dramatically lower the viscosity of a monoclonal antibody solution, herein we have determined these effects not to be general. Separately, we have found that hydrophobic ionic excipients, both anionic and cationic, substantially decrease the viscosity of concentrated (300-400 mg/mL) aqueous solutions of bovine serum albumin and γ-globulin. The more hydrophobic the excipient, the greater its viscosity-lowering effect is. With cationic ones, the concomitant contribution of the counter-ion broadly follows the chaotropic order. The most potent excipients lower the viscosity over fourfold to levels far below the 50 cP threshold for subcutaneous injections. The observed viscosity reductions are rationalized in terms of three-dimensional transient protein networks formed in concentrated solutions due to hydrophobic and, to a lesser extent, ionic interactions. These reversible protein aggregates are responsible for strong resistance to flow in concentrated protein solutions and hence their high viscosity; hydrophobic ions apparently effectively compete for these interprotein interactions, thereby giving rise to less viscous solutions.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21246510     DOI: 10.1002/bit.22983

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  18 in total

1.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

2.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 3.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

4.  Do clustering monoclonal antibody solutions really have a concentration dependence of viscosity?

Authors:  Jai A Pathak; Rumi R Sologuren; Rojaramani Narwal
Journal:  Biophys J       Date:  2013-02-19       Impact factor: 4.033

5.  Non-aqueous suspensions of antibodies are much less viscous than equally concentrated aqueous solutions.

Authors:  Charudharshini Srinivasan; Alisha K Weight; Till Bussemer; Alexander M Klibanov
Journal:  Pharm Res       Date:  2013-03-30       Impact factor: 4.200

6.  Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.

Authors:  Chaitanya Sudrik; Theresa Cloutier; Phuong Pham; Hardeep S Samra; Bernhardt L Trout
Journal:  MAbs       Date:  2017-07-31       Impact factor: 5.857

7.  Multiscale Coarse-Grained Approach to Investigate Self-Association of Antibodies.

Authors:  Saeed Izadi; Thomas W Patapoff; Benjamin T Walters
Journal:  Biophys J       Date:  2020-04-29       Impact factor: 4.033

8.  Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies.

Authors:  Zheng Guo; Alvin Chen; Roger A Nassar; Bernhard Helk; Claudia Mueller; Yu Tang; Kapil Gupta; Alexander M Klibanov
Journal:  Pharm Res       Date:  2012-06-13       Impact factor: 4.200

Review 9.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

10.  Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.

Authors:  Jessica J Hung; Barton J Dear; Aileen K Dinin; Ameya U Borwankar; Sumarth K Mehta; Thomas T Truskett; Keith P Johnston
Journal:  Pharm Res       Date:  2018-04-30       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.